Vipidia 25 mg

Vipidia (mbadamba) Rating: 177

Emeputa: A na-akọwa
Mwepụta Mwepụta:

• Tab. 12.5 mg, 28 PC., Ọnụahịa site na 973 rubles
• Tab. 25 mg, 28 PC., Ọnụ ahịa site na 1282 rubles

Ọnụ ahịa Vipidia na ụlọ ahịa ọgwụ dị n'ịntanetị
Ntụziaka maka ojiji

Vipidia bụ ihe nnọchianya nke hypoglycemic dị na mbadamba nwere alogliptin. Na-enye mbelata glycosylated haemoglobin na glucose. E gosipụtara ya n'ụdị ụdị ọrịa mellitus 2 dị n'ụdị monotherapy, yana yana njikọ yana ndị ọrụ hypoglycemic ndị ọzọ. Usoro ezigbo usoro bụ 25 mg / ụbọchị, ana agbanyeghị nri. Contraindicated na ọrịa shuga ketoacidosis, ụdị shuga mellitus nke 1, nnukwu obi daa, akụrụ na ọrịa imeju. Nsonaazụ nwere ike ịgụnye isi ọwụwa, ọnya ọgbụgba, ọnya, ọrịa na-efe efe nke akụkụ ENT. Edeghị ụmụaka n'okpuru afọ 18 na ụmụ nwanyị dị ime n'ihi enweghị ozi na ngwa ahụ.

Analogs nke ọgwụ Vipidia

Ihe analogue dị ọnụ ala site na 863 rubles.

Emeputa: Merck Sante SAA.S. (France)
Mwepụta Mwepụta:

• Mbadamba 500 mg, 30 PC., Ọnụ sitere na 110 rubles
• Mbadamba 1000 mg, 30 PC., Ọnụ ahịa site na 185 rubles

Ọnụ ahịa Glucophage na ụlọ ahịa ọgwụ dị n'ịntanetị
Ntụziaka maka ojiji

Ọgwụ French maka ịgwọ ụdị ọrịa shuga 2. Erere na mbadamba ụrọ nke nwere 500 mg na 1000 mg nke metformin dịka naanị ihe eji arụ ọrụ. Enwere contraindications, yabụ, tupu iwere Glucofage, ọ dị mkpa ka ịkpọtụrụ ọkachamara.

Ihe analogue dị ọnụ ala site na 182 rubles.

Emeputa: Novartis (Switzerland)
Mwepụta Mwepụta:

• Mbadamba 50 mg, 28 PC., Ọnụahịa site na 791 rubles
• Mbadamba 1000 mg, 30 PC., Ọnụ ahịa site na 185 rubles

Ọnụ ego Galvus na ụlọ ahịa ọgwụ dị n'ịntanetị
Ntụziaka maka ojiji

Galvus bụ nkwadebe mbadamba maka ọgwụgwọ maka ụdị shuga mellitus nke 2 na-adabere na vildagliptin na usoro nke 50 mg. Enwere ike ịkọwa ya dịka monotherapy yana akụkụ nke ọgwụgwọ njikọta na nri adịghị mma na mmega ahụ.

Ihe analogue dị ọnụ ala site na 795 rubles.

Emeputa: Hemofarm A.D. (Serbia)
Mwepụta Mwepụta:

• Tab. 500 mg, 60 PC., Ọnụahịa site na 178 rubles
• Mbadamba 1000 mg, 30 PC., Ọnụ ahịa site na 185 rubles

Ọnụ ahịa Metformin na ụlọ ahịa ọgwụ dị n'ịntanetị
Ntụziaka maka ojiji

Metformin bụ ọgwụ hypoglycemic nke Serbian maka ojiji nke ime. Ngwakọta nke mbadamba nkume ahụ nwere ihe mejupụtara arụ ọrụ nke otu aha na usoro nke 500 ma ọ bụ 850 mg. Edere ya maka ọgwụgwọ nke ọrịa shuga 2 (na ndị okenye), karịchaa n'ihe banyere oke ibu.

Ihe analogue dị ọnụ karịa 799 rubles.

Emeputa: Bristol Myers Squibb (USA)
Mwepụta Mwepụta:

• Mpempe 5 mg, 30 PC., Ọnụahịa site na 1772 rubles
• Mbadamba 1000 mg, 30 PC., Ọnụ ahịa site na 185 rubles

Ahịa maka Onglisa na ahịa ọgwụ n'ịntanetị
Ntụziaka maka ojiji

Onglisa bụ ọgwụ America maka ịgwọ ụdị ọrịa shuga mellitus nke 2 dabere na saxagliptin na usoro ọgwụ nke 2.5 ma ọ bụ 5 mg. Edere ya na mgbakwunye na mmega ahụ na nri iji meziwanye njikwa glycemic.

Ihe analogue dị ọnụ karịa 1236 rubles.

Emeputa: Merck Sharp na Dome (USA)
Mwepụta Mwepụta:

• Mbadamba 100 mg, 28 PC., Ọnụahịa site na 2209 rubles
• Mbadamba 1000 mg, 30 PC., Ọnụ ahịa site na 185 rubles

Ahịa maka Januvia na ụlọ ahịa ọgwụ dị n'ịntanetị
Ntụziaka maka ojiji

Januvia bu ogwu ndi America maka oria oria. Ngwakọta ọrụ: sitagliptin (n'ụdị phosphate monohydrate) 100 mg. Enwere ike iji ya dị ka mgbakwunye na mmega ahụ na nri iji chịkwaa ọbara shuga.

Ihe analog ahụ dị ọnụ karịa 675 rubles.

Emeputa: Beringer Ingelheim (Austria)
Mwepụta Mwepụta:

• Mpempe 5 mg, 30 PC., Ọnụ sitere na 1648 rubles
• Mbadamba 1000 mg, 30 PC., Ọnụ ahịa site na 185 rubles

Ahịa maka Trazhenta na ọgwụ ọgwụ dị n'ịntanetị
Ntụziaka maka ojiji

Trazhenta - ọgwụ ndị Ọstrịa chọrọ iji gwọọ ụdị ọrịa shuga abụọ nke ọrịa mellitus, ka a ga-edenye ya ka ọ bụrụ ọgwụ ma ọ bụ akụkụ nke ọgwụgwọ njikọta. Naanị otu ihe mejupụtara na ihe mejupụtara bụ linagliptin na usoro nke 5 mg. Azọpụtaghị Trazenta maka ọrịa shuga 1, n'oge afọ ime, na-enye nwa, yana ụmụaka ndị gbara afọ 18.

Leasedị ntọhapụ, ihe mejupụtara na nkwakọ

A na-eme ọgwụ ahụ n'ụdị mbadamba osisi oval nke mkpuchi membrane. Usoro ọgwụgwọ:

• 12.5 mg - mbadamba odo
• 25 mg - akwara na-acha ọbara ọbara.

A na-ere ngwaahịa a na ngwugwu kaadiboodu. Nkwakọ ngwaahịa: 4 blisters, nwere mbadamba 7, ngụkọta nke mkpụrụ 28 dị na mkpọ.

Ihe na - arụ ọrụ nke ọgwụ ahụ bụ alogliptin. Ihe inyeaka:

• stereta magnesium,
• sodium croscarmellose
• microcrystalline cellulose,
• Hyprolose

Igwe mkpuchi ihe onyonyo a mebere:

• hypromellose,
• iron oxide dye
• titanium dioxide
• macrogol
• ink isi awọ F1

Omume ọgwụ

Alogliptin bụ dipoptidyl peptidase-4 inhibitor na-ahọrọ nke ukwuu. DPP-4 bụ enzyme bụ isi na - eme ka ngbawanye ngwa ngwa nke homonụ nke ezinụlọ incretin. Karịsịa, ọ bụ polypeptide insulinotropic insulinotropic (HIP) na gluptagon-dị ka peptide-1 (GLP-1). A na-emepụta homonụ ndị a na eriri afọ, ọkwa ha dịgasịkwa iche dabere na nri a na-eri. Nsonaazụ nke HIP na GLP-1 bụ iji mee ka njikọ nke insulin na-arụ ọrụ na pancreas.

Peptide glucose na-enyere aka belata glucagon ma belata imepụta glucose na imeju. Site na mgbanwe ọ bụla na ọkwa nke incretins n'okpuru mmetụta nke alogliptin, mmepụta insulin na-abawanye ma glucagon na-ebelata site na mmụba shuga. N'ime ndị nwere ọrịa shuga, mgbanwe ndị dị otú a na-eduga n'inyocha haemoglobin glycosylated na usoro ọbara ndị ọzọ tupu nri.

Mlọ ọgwụ

Ọgwụ n’otu aka ahụ metụtara onye ahụ ike na onye ọrịa ọria mamịrị. Alogliptin na-abanye n'ime ahụ ihe fọrọ nke nta ka ọ bụrụ 100%, n'agbanyeghị nri riri. Na otu mbadamba ihe, a na-etinye ihe dị n'ọrụ n'ime ọbara ngwa ngwa, ebe mgbe elekere 1 ruo 2 gasịrị na-enweta ntinye ọgwụ kachasị.

Alogliptin na-eme ka e kesaa ya nke ọma na akwara. Mmekọrịta ya na protein ndị dị na plasma bụ ihe dịka 20-30%. Site n'iji ọgwụ ahụ ogologo oge, mmụba nke ihe arụ ọrụ na-arụ ọrụ n'ahụ, dịka data ụlọ ọgwụ si kwuo, ahụghị ka ndị ahụ gbasiri ike ma ọ bụ ndị ọrịa. N’ime awa iri abụọ na abụọ ka ị theụchara ọgwụ ahụ, akụrụ 70% nke ihe ahụ bụ akụrụ na-agbanweghi agbanwe, 13% site na eriri afọ.

Edere Vipidia maka ọrịa shuga 2. Ngwá ọrụ na-enyere ndị ọrịa aka nke ọma, ọbụlagodi na enweghị nrube isi na nri na enweghị mmega ahụ dị mkpa. Enwere ike iji ọgwụ ahụ mee ihe dị ka monotherapy. Nwere ike ị itụ ya na ọgwụ ndị ọzọ na - enyere aka belata ịta shuga n'ọbara.

Ihe ngbanwe

Dika ogwu ogwu obula, Vipidia nwere oke ya. Jiri nlezianya gụọ ya.

Ọgwụ ekwesịghị ị notụ mmanya:

• hypersensitivity nke anụ ahụ n'ihe ọ bụla nke ọgwụ ahụ,
• ụdị shuga 1
• ọrịa mamịrị ketoacidosis,
• ike ọgwụgwụ nke obi
• nnukwu mmebi imeju,
• ime na lactation,
• ụmụaka na-erubeghị afọ 18.

Site kpachara anya mgbe:

• ọria aru
• agafeghị oke gbasara akụrụngwa,

Ntụziaka maka ojiji (usoro)

Ekwesịrị iji ọnụ ghaa Vipidia, ma tupu nri ma mgbe nri gasịrị. A na-atụ aro ka ọ ghara iji karịa 25 mg kwa ụbọchị. Edere ya oge ụfọdụ yana ọgwụ ndị ọzọ, dị ka:

Site na nchịkwa nkwonkwo nke Vipidia na metformin ma ọ bụ thiazolidinedione, dose ahụ na-agbanwe agbanwe. Iji wepu ihe ize ndụ nke hypoglycemia, mgbe edepụtara ọgwụ ahụ n'otu oge na insulin, ọ dị mkpa iji belata usoro nke ikpeazụ. Y’oburu n’inweghi echefu ị drinku ogwu a, ikwesiri idozi ya ozugbo enwere ike. Ma n'otu oge, okpukpu abụọ agaghị agbakọta.

Ọkwa glucose dị n'ọbara na-adabere kpọmkwem n’ihe dị n’ime alogliptin dị n’ime ahụ. Maka nke a, akwadoghị ịwụnye ọgwụ.

Nsonaazụ

Onwere oge ufodu oria na adighi nma site na ogwu Vipidia. Onye ọrịa ahụ nwere ike ime mkpesa maka:

• isi ọwụwa
• akụkụ iku ume iku ume
• nasopharyngitis,
• mgbu n’afọ
• itching na akpụkpọ ahụ ọkụ,
• mmepe nke pancreatitis,
• guzobe ọdịda akụrụngwa ọdịda.

Ọ bụrụ n ’ụdị ihe mgbaàmà ndị a ka amata, ị kwesịrị ịgwa dọkịta gị. Naanị ya nwere ike kpebie ịga n’ihu ọgwụ ahụ ma ọ bụ na ọ gaghị. Ngosipụta ike nke mgbaàmà ndị dị n'elu chọrọ ịhapụ ọgwụ ozugbo.

Dodoụbiga ya ókè

Iri ihe mberede enweghị ihe ọ bụla ga-eyi ụmụ mmadụ. Achọrọ enyemaka nke dọkịta naanị mgbe ọ na-anabataghị Vipidia ma ọ bụ mgbe ị na-a medicationụ ọgwụ site n'aka ndị mmadụ na-arịa ọrịa ndị dị na ndepụta contraindications. Ihe enyemaka mbu maka ịdoụbiga mmanya ókè - lavage gastric.

Ntụziaka pụrụ iche

Ojiji nke Vipidia na insulin na ọgwụ ndị ọzọ na-ebelata shuga dị ọbara chọrọ nhazi nke usoro iji gbochie mmepe nke hypoglycemia. Dabere na ọmụmụ banyere ụlọ ọgwụ, njikọta nke alogliptin na ngwaọrụ ọgwụ ndị ọzọ egosighi mgbanwe mgbanwe akpọrọ.

Alogliptin nwere mmetụta dị ukwuu n'ahụ ahụ, yabụ n'oge ọgwụgwọ ị kwesịrị ịjụ ị takeụ mmanya.

Ọgwụ "Vipidia" anaghị akpata ụra ụra, yabụ ịnyaghị ịnya ụgbọ ala na ihe ndị ọzọ chọrọ ịbawanye nlebara anya.

Ihe dị mkpa: ọmụmụ egosila na ọgwụ a anaghị emetụta imeju nke ọma, na-emebicha ọrụ ya. Ruo n’ókè nke nnukwu ọrịa pancreatitis nwere ike ime. Ya mere, tupu ị using were ọgwụ ahụ, ọ dị mkpa iji nyochaa nyocha zuru oke ma tulee uru na ọghọm niile.

N'ihi enweghi ihe omuma banyere onodu ojoo n’oge di ime ma nye ya ara, o kariri ị tou Vipidia.

Childrenmụaka na agadi

Ighazi ogwu banyere umu aka na umuaka noo n’agbata afo iri na asatọ n’agbanye oria ogwu n’ihi oria akuko a.

Ndị ọrịa gaferela afọ iri isii nwere ike ị drinkụ "Vipidiya". Achọghị usoro ị na-emebu. Agbanyeghị, ekwesịrị iburu n'uche na enwere ike nke mbelata na-arụ ọrụ akụrụ na umeji na-adabere n'ụkpụrụ amụrụ nke alogliptin.

Usoro na ọnọdụ nchekwa

Debe ọgwụ ahụ n'ọchịchịrị, dịkwa jụụ ụmụaka. Okwu a ga - eji mee ya bụ afọ atọ site na ụbọchị e wepụtara. Isbọchị emeputara bu ihe ichoro. Amachibidoro ị drugụ ọgwụ gwụrụ.

Pricegwọ nke Vipidia na ụlọ ahịa ọgwụ dịgasị iche dabere na usoro ị medicineụ ọgwụ na mpaghara obibi. Ná nkezi, ọ bụ 845 - 1390 rubles.

Ọgwụ anaghị ere ya, enwere ike ịzụta ya naanị site na ndenye ọgwụ.

Tụnyere ihe analogues

Ọ bụrụ na n'ihi ihe ụfọdụ ọgwụ anaghị adabara onye ọrịa, dọkịta na-achọ ọgwụ nwere ike dochie ya.

Ndepụta analogues nke ọgwụ "Vipidia":

Aha	Uru ọ bara
Galvus Met	Effectivezọ dị irè iji belata ọkwa shuga. Ọ na - enyere aka tufuo kilogram n'etinyeghị nri.	Ndepụta nke mmetụta ndị ọ na-akpata. Ọnụ ego ọgwụ ọjọọ riri elu.	Site na 780 rubles.
Alogliptin	Na-enyere aka ịme ka ọ̀tụ̀tụ̀ glucose dị ala. Ọ naghị eme ka metabolism mụbara. Ọ dịghị mkpokọta, wepụ ya kpamkpam n'ahụ.	Enweghi ike iji ya maka oria akwara, imeju, na akwara. Ọgwụ adịghị ọnụ ala.	Site na 845 rubles.
Januvia	Na-akwalite ịbelata oke, belata agụụ, na-edozi usoro ọbara.	Efu. Ọ nwere ọtụtụ contraindications maka iji ya, ya mere ọ dị mkpa ka dọkịta depụta ọgwụ ahụ.	Site na 1350 rubles

Ọtụtụ nzaghachi sitere n'aka ndị ọrịa mamịrị nwere ọria na-a Vụ Vipidia dị mma. Mbadamba nkume ndị a belata shuga dị n'ọbara nke ọma, a na-anabata nke ọma, mana ha ga-eji ya naanị dị ka dọkịta si duzie ya. Ndị mmadụ enweghị mmasị n'eziokwu ahụ bụ na ọgwụ a dị oke ọnụ. Nke a bụ ụfọdụ ezigbo nyocha:

Achọpụtara m na ọrịa shuga afọ ise gara aga. Edebanye aha ya na endocrinologist, aụọ ọtụtụ ọgwụ. Mana izu ole na ole gara aga, shuga bidoro rute na nkeji iri na asatọ. Dọkịta nyere m Vipidia. Ana m ewere naanị otu mbadamba kwa ụbọchị, shuga bụ ihe nkịtị. Obi dị m ụtọ nke ukwuu. Achọpụtara m n'onwe m na ọgwụ a bụ naanị otu uru.

Vipidia dochie insulin nke ọma. N’eji ya atụnyere ya, naanị ihe ọ ga-ewe bụ ka ewere ya ọgwụgwọ bụ otu ugboro n’ụbọchị. Ọ baghị uru idobe nri. Enwere m ọrịa shuga, mbadamba ndị ahụ na-eme ka ọ̀tụ̀tụ̀ glucose dị n'ọbara, n'ihi ya ajụrụ m insulin ogologo oge. Eziokwu dị mgbagwoju anya maka ọnụahịa, ọgwụ adịghị ọnụ ala, ọ bụghị mmadụ niile ga-emeli ya. Mana, n'ezie, enwere mgbakwunye. M na-akwado ya onye ọ bụla.

Enwere m ọrịa shuga 2. A gwọchara ya, were ọgwụ kwa ụbọchị, mana glucose belatara, wee nwetakwa uru iri na abụọ. Enwere ọnọdụ nke mmeghachi omume hypoglycemic, ọdịda dị ike nke shuga. Dọkịta nyere m Vipidia. Enwere m obi anụrị na ọgwụ a. A na m a onlyụ naanị otu mbadamba n'ụtụtụ ma ihe niile bụ ihe nkịtị. Ọ bụ ezie na ọnụ dị oke ọnụ, mana anaghị m ahụkwa mgbanwe n’arụ ọbara ma wetuo obi ụbọchị niile. M na-akwado ya onye ọ bụla.

Dọkịta nyere m ọgwụ iji zụta ọgwụ “Vipidia”. Enwere m ọrịa shuga ruo ọtụtụ afọ. Ọ masịrị m ọgwụ a, ọ na-agbadata ihe ndị na-egosi glucose nke ọma. M na-a drinkụ mmanya naanị otu ugboro n’ụbọchị. Ọ nweghị contraindications mgbe gị na ọgwụ ndị ọzọ na-emekọrịta ihe, nke kachasị mma. Ọ naghị emetụta psyche ma ọ dịghị akpata ụra ụra. Amachibidoro ya ịnya ụgbọ ala. Enwere m afọ ojuju n'ihe niile, ọgwụgwọ dị mma nke anaghị ewetara m nsogbu ọ bụla.

Weputara udi ya na ihe mebere ya

A na-eme ọgwụ ahụ n'ụdị mbadamba nwere 25 mg nke ihe na-arụ ọrụ - alogliptin benzoate. Egwuregwu inyeaka na-emezi isi nke mbadamba nkume ndị a:

• microcrystalline cellulose,
• stereta magnesium,
• mannitol
• sodium croscarmellose,
• hyprolose.

Ihe ndị dị n’elu mbadamba nkume ahụ bụ ihe nkiri nwere ihe mejupụtara hypromellose, titanium dioxide, macrogol 8000, ihe eji acha odo odo na-adabere na ironide. Mbadamba 25 mg bụ uhie uhie.

Omume ọgwụ

Ọgwụ a bụ nke klaasị hypoglycemic agents n'ihi nhọrọ mkpesa nke ọrụ dipeptidyl peptidase-4. DPP-4 bụ isi ihe dị na enzyme so na mmebi ngwa ngwa nke homonụ nke mmiri ọgwụ ana - enteroglucagon na peptide insulinotropic, nke dabere n'ọkwa glucose (HIP).

Hormones site na klaasị nke incretins ka anapụtara n'ime eriri afọ. Theta onyinye kemịkal na-abawanye na nri oriri. Glucagon dị ka peptide na GUI na-abawanye njikọ insulin na obere agwaetiti pancreatic nke Langerhans. Enteroglucagon n’otu oge na - egbochi njikọ glucagon ma gbochie gluconeogenesis na hepatocytes, nke na - eme ka ịbawanye ụba nke plasma. Alogliptin na-eme ka mmiri ọgwụ insulin dịkwuo elu, dabere na shuga ọbara.

Ihe ngosi maka ojiji

Edere ọgwụ ahụ maka ndị ọrịa maka ịgwọ ụdị ọrịa shuga na-arịa insulin na-abụghị insulin na inye aka nke nchịkwa glycemic megide nzụlite nke usoro ọgwụgwọ nri na mmega ahụ. Maka ndị ọrịa okenye, enwere ike ịkọ ọgwụ ahụ dị ka monotherapy, yana dịka akụkụ nke ọgwụgwọ siri ike na insulin ma ọ bụ ọgwụ hypoglycemic ndị ọzọ.

Etu esi ewere Vipidia 25?

Mbadamba nkume ndi a bu ka eji eme ihe. A na-atụ aro ka iji ọgwụ ahụ were ọgwụ nke 25 mg otu ugboro n'ụbọchị, n'agbanyeghị nri nri. Agaghị edetu nkeji nke ọgwụ ahụ, n'ihi na ihe mebiri emebi na-ebelata ọnụego nnabata nke alogliptin na obere eriri afọ. Ejila okpukpu abụọ.Onye ọrịa tụfuru ọgwụ n’ihi ihe ọ bụla kwesịrị iwere ya ozugbo enwere ike.

Ọrịa mamịrị

Ndị ọkachamara n'ihe banyere nri na-atụ aro ịre mbadamba Vipidia mgbe ha risịrị nri mgbe ọkwa shuga dị n'ọbara bilitere. Mgbe ị na-edepụta ọgwụ dịka ngwa ọzọ maka ọgwụgwọ na Metmorphine ma ọ bụ Thiazolidinedione, ọ dịghị mkpa ịgbanwe usoro usoro nke ikpeazụ.

Site na njikwa ihe ndị ọzọ dị na usoro sulfonylurea, a na-ebelata ọgwụ ha iji gbochie mmepe nke steeti hypoglycemic. N'ihi ọghọm hypoglycemia nwere ike ịdị, ọ dị mkpa iji chịkwaa ọkwa shuga n'oge ọgwụgwọ na Metformin, homonụ pancreatic na Thiazolidinedione na Vipidia.

N'ihi ọghọm hypoglycemia nwere ike ịdị, ọ dị mkpa iji chịkwaa ọkwa shuga n'oge ọgwụgwọ Metformin.

Ọrịa sistem

Na nzụlite usoro ahụ ji alụso ọrịa ọgụ, ọrịa na-efe efe nke akụkụ okuku ume na mmepe nke nasopharyngitis ga-ekwe omume.

Na anụahụ

N'ihi nsụ anụ ahụ, akpụkpọ ahụ ma ọ bụ itching nwere ike apụta. Na usoro ọgwụgwọ, ọdịdị nke ọrịa Stevens-Johnson syndrome, urticaria, ọrịa na-efe efe nke anụahụ.

N'ime ndị ọrịa arara n'ọdịdị mmeghachi omume anaphylactoid, urticaria, a na-ahụ ntụpọ Quincke. N'ọnọdụ siri ike, ure ịba ọcha n'anya na-ebilite.

Jiri n'oge ime na lactation

Emebeghị nnyocha banyere nyocha nke ọgwụ ahụ n'ahụ ụmụ nwanyị n'oge afọ ime. N'oge nyocha nke ụmụ anụmanụ, enweghi mmetụta ọjọọ nke ọgwụ ahụ n'ahụ akụkụ ahụ nke usoro ịmụ nwa nke nne, ẹmbrayoxic, ma ọ bụ teratogenicity nke Vipidia. N'otu oge ahụ, maka ebumnuche nchekwa, enyeghị ọgwụ ọgwụ maka ụmụ nwanyị n'oge afọ ime (n'ihi ohere nke ịdaba na ịkụnye akụkụ ahụ na sistemụ na mmepe nke ẹmbrayonia).

Alogliptin ga-enwe ike ịpụta site na mammary glands, yabụ, n'oge oge ọgwụgwọ ọgwụ, a na-atụ aro ịhapụ ị abandonụ ara.

Ngwa maka ọrụ ezughi oke ọrụ

Na ọnụnọ nke ọdịda akwara dị nhịahụ n'etiti mkpochapụ creatinine (Cl) site na 50 ruo 70 ml / min, enweghị mgbanwe ndị ọzọ na-eme na usoro dosing. Site na Cl sitere na 29 ruo 49 ml / min, ọ dị mkpa iji belata ụkpụrụ kwa ụbọchị gaa na 12.5 mg maka otu ọgwụ.

Na ọnụnọ nke ọdịda akwara dị nhịahụ n'etiti mkpochapụ creatinine (Cl) site na 50 ruo 70 ml / min, enweghị mgbanwe ndị ọzọ na-eme na usoro dosing.

Site na ọgbụgba akwara siri ike (Cl erughị erughị 29 ml / min), amachibidoro ọgwụ a.

Mmekọrịta na ọgwụ ndị ọzọ

Ọgwụ a enweghị mmekọrịta ọgwụ na mmekọrịta n'otu oge nke Vipidia na ọgwụ ndị ọzọ. Ọgwụ ahụ egbochighị ọrụ nke cytochrome isoenzymes P450, monooxygenase 2C9. Nmekorita ya na ihe p-glycoprotein. Alogliptin n'oge ọmụmụ nke ọgwụ emetụtaghị mgbanwe na ọkwa nke caffeine, Warfarin, Dextromethorphan, mgbochi afọ na plasma.

Ọgwụ a anaghị emetụta mgbanwe na ọkwa nke Dextromethorphan na ahụ.

Mmanya ndakọrịta

N’oge a na-eji ọgwụ a, a machibidoro ị drinkụ mmanya na-aba n’anya. Ethanol dị n’ime ihe ọholicụholicụ na-egbu egbu nwere ike imebi imeju na-egbu egbu n’ihi nsonaazụ na-egbu egbu na hepatocytes. Mgbe ị na-ewere Vipidia, a na-enwekwu mmetụta utịp megide sistemụ ịba ọcha n'anya. Mmanya ethyl na-akpata mgbochi nke usoro ụjọ ahụ, na-egbochi nrugharị ọbara ma nwee ọria diuretic. N’ihi nsonaazụ mmanya n’arụ n’arụ, a na-ebelatazi ọgwụgwọ nke ọgwụ.

Ihe ndi ozo nke ogwu nwere udiri ọgwụ di iche na udiri kemikal nke ihe ndi ahu no n’oru gunyere:

Ọ bụ dibia a na-aga na-ahọrọ ọgwụ synonym dabere na ngosipụta nke ịka ọbara ọbara yana ọnọdụ izugbe nke onye ọrịa. A na-edochi mmegharị naanị mgbe enwere ọgwụgwọ ọgwụgwọ ma ọ bụ na-emegide mmeghachi omume dị njọ.

Ihe ngosi na contraindications maka ojiji

Vipidia bụ ọgwụ ọgwụ hypoglycemic nke ọgwụ. A na-eji ngwa a na ọgwụgwọ nke ọrịa shuga 2. Ọgwụ a na-arịa ọrịa shuga na-enyere aka melite nchịkwa nke glycemia na plasma ọbara nke onye ọrịa. A na-eji ọgwụ eme ihe mgbe iji usoro ọgwụgwọ nri na mmega ahụ arụ ọrụ adịghị enye nsonaazụ achọrọ.

Enwere ike iji ọgwụ ahụ dị ka naanị akụrụngwa n'oge monotherapy. Na mgbakwunye, enwere ike iji Vipidia jikọta ya na ọgwụ hypoglycemic ndị ọzọ na ọgwụgwọ nke ọrịa shuga ụdị ọrịa shuga 2 nke usoro ọgwụgwọ dị mgbagwoju anya.

Enwere ike iji ọgwụ a na-agwọ ọrịa shuga yana insulin.

Dịka ọgwụ ọ bụla, Vipidia nwere ọtụtụ contraindications na-amachi ị ofụ ọgwụ ahụ. Ihe mgbochi mbu bu dika ndi a:

• ọnụnọ nke ụdị shuga 2 na onye ọrịa, hypersensitivity na alogliptin na akụkụ inyeaka nke ọgwụ ahụ,
• onye ọrịa ahụ nwere ọrịa shuga n'ụdị insulin
• nchọpụta nke ihe ịrịba ama nke ketoacidosis na-etolite n'ahụ onye ọrịa megide mmalite nke ọrịa shuga,
• njirimara nke nnukwu obi daa,
• nsogbu na umeji, nke sochiri ọnọdụ nke enweghi ike ọrụ,
• mmepe nke akụrụngwa ọrịa akụrụ siri ike, nke sokwa na ihe na-ada ada,
• oge ịmụ nwa,
• oge lactation
• Afọ ọrịa dị ka afọ 18.

Ekwesịrị ịkpachara anya mgbe onye ọrịa nwere ọrịa ọrịa pancreatitis na oke ọria ya na arụ ọrụ akụrụ na umeji.

Na mgbakwunye, ekwesịrị ịkpachara anya mgbe ị na-eji ọgwụ ahụ dịka akụrụngwa na ọgwụgwọ dị mgbagwoju anya nke ụdị shuga 2.

Ntuziaka maka iji ọgwụ ahụ

A na-ewere ọgwụ ọnụ. Ọtụtụ mgbe, usoro ọgwụgwọ ọgwụgwọ akwadoro maka ojiji bụ 25 mg.

Edere ụzọ ka mma ị aụ ọgwụ ọ byụ byụ site n'aka dibia bekee na –echebara nsonaazụ ndị enwetara n'oge nyocha nke ahụ onye ọrịa na njiri mara ya.

A na-a drugụ ọgwụ ahụ otu ugboro n’ụbọchị, a na-a drugụ ọgwụ ahụ n’agbanyeghi usoro nhazi nri. Theakingụ ọgwụ ahụ bụ ị drinkingụ nnukwu mmiri.

Ojiji nke ogwu nwere ike ime na ihe ndia:

1. Dị ka ọgwụ maka monotherapy nke ụdị ọrịa shuga mellitus 2.
2. Na mmejuputa iwu-ogwu aghara nke oria, dika akwara dika aru ike di. Enwere ike ị nweta ya na vipidia, metformin, protein sulfonylurea ma ọ bụ insulin.

N'ihe banyere Vipidia na Metformin, a chọghị ime mgbanwe iji dozie ọgwụ ahụ. Imezi dose mgbe ị na-eji ọgwụ ahụ na ọgwụ ndị bụ sọlfọlurea ma ọ bụ insulin.

A na-edozi ọgwụ ahụ iji gbochie mmalite nke akara hypoglycemic na onye ọrịa nwere ọrịa mellitus.

Ekwesịrị ịkwalite ịkpachara anya mgbe ị na-eji Vipidia na Metformin Teva na thiazolidinedione na ọgwụgwọ ọrịa shuga.

Mgbe akara ngosipụta mbụ nke hypoglycemia pụtara, usoro nke Metformin na thiazolidinedione kwesịrị ibelata.

Mgbe ị na-ewere Vipidia, nsonaazụ ndị a nwere ike ime:

• na ụjọ usoro, ihe ndapụta ugboro ugboro,
• site na akwara afọ, ọdịdị nke ihe mgbu n'ime afọ, na-atụba ọdịnaya nke afọ n'ime esophagus, mmepe nke ihe ịrịba ama nke nnukwu pancreatitis,
• site na sistemu ịba ọcha n'anya, ihe na-emebi imeju,
• mmeghachi omume nfụkasị ahụ nwere ike ịda n'ụdị itching, rashes, edere Quincke,
• mbufụt nke mualsa imu na pharynx ga-ekwe omume,

Na mgbakwunye, mmetụta ndị sitere na sistem nwere ike ịpụta, na-egosipụta dịka anafilas.

Nyocha na Vipidia 25

Na nzukọ ịntanetị, enwere nkwenye dị mma sitere na ndị na-ere ọgwụ na ntinye anya maka iji ọgwụ ahụ.

Anastasia Sivorova, endocrinologist, Astrakhan.

Ngwá ọrụ dị irè n'ọgụ megide ọrịa shuga 2. Ndị ọrịa nabatara nke ọma. N'ime omume ụlọọgwụ, ezutaghị hypoglycemia. E kwesịrị iburu mbadamba oge 1 kwa ụbọchị na-ejighị atụmatụ nlezianya usoro onunu ogwu. Ya mere, ihe nnọchianya hypoglycemic sitere na ọgbọ ọhụrụ, yabụ adịghị enye aka na-abawanye ụba nke ahụ. A na-arụ ọrụ arụmọrụ nke mkpụrụ ndụ beta nke pancreatic.

Alexey Barredo, endocrinologist, Arkhangelsk.

Enwere m mmasị na iji ọgwụ ahụ ogologo oge, ngosipụta na-adịghị mma anaghị etolite. Mmetụta ọgwụgwọ nwere mmetụta hypoglycemic dị nro, mana anaghị ahụ anya ozugbo. Ọ dị mma iji - 1 oge kwa ụbọchị. Ezigbo uru maka ego. Ọ naghị ebute mmeghachi omume nfụkasị na ndị ọrịa.

Mgbakwunye ọgwụ a bụ Januvia.

Gabriel Krasilnikov, 34 afọ, Ryazan.

Ana m a Vụ Vipidia na ọgwụ 25 mg ruo afọ 2 na njikọ 500 mg nke Metformin n'ụtụtụ mgbe erichara. Na mbu, o jiri insulin dika atụmatụ 10 + 10 + 8. O nyeghị aka belata shuga n'ụzọ dị irè. Ihe mbadamba ọrụ dị ogologo. Naanị mgbe ọnwa atọ gasịrị, shuga malitere ịda, ma mgbe ọnwa isii gasịrị, glucose sitere na 12 dara na 4.5-5.5. Na-aga n’ihu ịnọ 5.5. Enwere m mmasị na ịdị arọ ahụ belatara: site na 114 ruo 98 n'arọ na mmụba nke 180 cm. Mana ịkwesịrị ịgbaso ndụmọdụ niile.

Analogs na ihe mejupụtara ma gosipụta maka ojiji

Aha	Ọnụahịa na Russia	Ọnụahịa na Ukraine
Nesina alogliptin	--	--

N'elu ndepụta ọgwụ analogues, nke Ndị nọchiri Vipidia, bụ nke kachasị mma n'ihi na ha nwere otu ihe mejupụtara nke ihe ndị na-arụ ọrụ ma na-emekọ ihe dabere na ngosipụta maka ojiji

Analogs site na ngosipụta na usoro eji

Aha	Ọnụahịa na Russia	Ọnụahịa na Ukraine
Januvia sitagliptin	1369 rub	277 UAH
Galvus vildagliptin	245 nkp	895 UAH
Onglisa saxagliptin	1472 nkp	48 UAH
Trazhenta linagliptin	89 nkp	1434 UAH

Ngwakọta dị iche iche, nwere ike yikọ ọnụ na njiri na usoro nke ngwa

Aha	Ọnụahịa na Russia	Ọnụahịa na Ukraine
Rosiglitazone enyere aka, metformin hydrochloride	--	--
Bagomet Metformin	--	30 UAH
Glucofage metformin	12 nkp	15 UAH
Glucophage xr metformin	--	50 UAH
Reduxin Met Metinin, Sibutramine	20 nkp	--
Dianormet	--	19 UAH
Diaformin metformin	--	5 UAH
Metformin metformin	13 nkp	12 UAH
Metformin sandoz metformin	--	13 UAH
Siofor	208 rub	27 UAH
Mpempe usoro metformin hydrochloride	--	--
Emnorm EP Metformin	--	--
Megifort Metformin	--	15 UAH
Metamine Metformin	--	20 UAH
Metamine SR Metformin	--	20 UAH
Metfogamma metformin	256 rub	17 UAH
Tefor metformin	--	--
Glycometer	--	--
Glycomet SR	--	--
Formethine	37 nkp	--
Metformin Canon metformin, ovidone K 90, stachi ọka, crospovidone, magnesium stearate, talc	26 nkp	--
Insuffor metformin hydrochloride	--	25 UAH
Metformin-teva metformin	43 nkp	22 UAH
Diaformin SR metformin	--	18 UAH
Mepharmil Metformin	--	13 UAH
Metformin Farmland Metformin	--	--
Glibenclamide Glibenclamide	30 nkp	7 UAH
Maninyl Glibenclamide	54 nkp	37 UAH
Glibenclamide-Health Glibenclamide	--	12 UAH
Glyurenorm glycidone	94 rub	43 UAH
Bisogamma Glyclazide	91 nkp	182 UAH
Glidiab Glyclazide	100 rub	170 UAH
Diabeton MR	--	92 UAH
Diagnizide mr Gliclazide	--	15 UAH
Glidia MV Gliclazide	--	--
Glykinorm Gliclazide	--	--
Gliclazide Gliclazide	231 nkp	44 UAH
Glyclazide 30 MV-Indar Glyclazide	--	--
Glyclazide-Health Gliclazide	--	36 UAH
Glioral Glyclazide	--	--
Diagnizide Gliclazide	--	14 UAH
Diazide MV Gliclazide	--	46 UAH
Osliklid Gliclazide	--	68 UAH
Diadeon gliclazide	--	--
Glyclazide MV Gliclazide	4 rub	--
Amaril	27 nkp	4 UAH
Glemaz glimepiride	--	--
Glian glimepiride	--	77 UAH
Glimepiride Glyride	--	149 UAH
Glimepiride diapiride	--	23 UAH
Ọlta	--	12 UAH
Glimax glimepiride	--	35 UAH
Glimepiride-Lugal glimepiride	--	69 UAH
Clay glimepiride	--	66 UAH
Diabrex glimepiride	--	142 UAH
Meglimide glimepiride	--	--
Melpamide Glimepiride	--	84 UAH
Perinel glimepiride	--	--
Glempid	--	--
Glim	--	--
Glimepiride glimepiride	27 nkp	42 UAH
Glimepiride-teva glimepiride	--	57 UAH
Glimepiride Canon glimepiride	50 ite	--
Glimepiride Pharmstandard glimepiride	--	--
Dimaril glimepiride	--	21 UAH
Diamlaid glamepiride	2 ite	--
Micronized Amaryl M Limepiride, Metformin Hydrochloride	856 rub	40 UAH
Glibomet glibenclamide, metformin	257 nkp	101 UAH
Glucovans glibenclamide, metformin	34 nkp	8 UAH
Dianorm-m Gliclazide, Metformin	--	115 UAH
Dibizid-m glipizide, metformin	--	30 UAH
Douglimax glimepiride, metformin	--	44 UAH
Duotrol glibenclamide, metformin	--	--
Gluconorm	45 nkp	--
Glibofor metformin hydrochloride, glibenclamide	--	16 UAH
Avandamet	--	--
Avandaglim	--	--
Janumet metformin, sitagliptin	9 nkp	1 UAH
Velmetia metformin, sitagliptin	6026 rub	--
Galvus Met vildagliptin, metformin	259 nkp	1195 UAH
Tripride glimepiride, metformin, pioglitazone	--	83 UAH
Mee metformin XR mechie, saxagliptin	--	424 UAH
Comboglyz Prolong metformin, saxagliptin	130 ite	--
Gentadueto linagliptin, metformin	--	--
Vipdomet metformin, alogliptin	55 nkp	1750 UAH
Sinjardi empagliflozin, metformin hydrochloride	240 nkp	--
Voglibose Oxide	--	21 UAH
Glutazone pioglitazone	--	66 UAH
Dropia Sanovel pioglitazone	--	--
Lixumia lixisenatide	--	2498 UAH
Guarem Guar resin	9950 rub	24 UAH
Insvada repaglinide	--	--
Novonorm Repaglinide	30 nkp	90 UAH
Repodiab Repaglinide	--	--
Baeta Exenatide	150 ite	4600 UAH
Baeta Long Exenatide	10248 rub	--
Viktoza liraglutide	8823 nkp	2900 UAH
Saxenda liraglutide	1374 rub	13773 UAH
Forksiga Dapagliflozin	--	18 UAH
Forsiga Dapagliflozin	12 nkp	3200 UAH
Invocana canagliflozin	13 nkp	3200 UAH
Jardins Empagliflozin	222 nkp	566 UAH
Dulaglutide Trulicity	115 nkp	--

Etu esi achọta analog dị ọnụ ala nke ọgwụ na-akwụ ụgwọ?

Iji chọta analog na-enweghị ego ọfụma n’egwuregwu, mkpụrụ ọgụgụ ma ọ bụ ntụgharị, nke mbụ anyị na-atụ aro ị attentiona ntị na ihe mejupụtara ahụ, ya bụ otu ihe ahụ na njiri mara maka ojiji. Otu ihe eji eme ọgwụ eme ihe ga-egosi na ọgwụ ahụ kwekọrọ na ọgwụ ahụ, ọgwụ kwekọrọ ma ọ bụ ọgwụ ọzọ. Agbanyeghị, echefula maka ihe ndị na - adịghị ike nke ọgwụ ndị yiri ya, nke nwere ike imetụta nchekwa na ịdị irè. Echefula banyere ntuziaka nke ndị dọkịta, ọgwụ ịchọrọ onwe gị nwere ike imerụ ahụ ike gị, yabụ gbaa dọkịta gị mgbe niile tupu ị usingụ ọgwụ ọ bụla.

Ntụziaka Vipidia

INWETA
iji ego eme ihe
Vipidia

Mpempe usoro onunu ogwu
12.5 mg na mbadamba 25-fim gbara agba

Ngwakọta
Otu mbadamba ihe
ihe na-arụ ọrụ: alogliptin benzoate 17 mg (ihe ruru 12.5 mg nke alogliptin) na 34 mg (nke ha na 25 mg nke alogliptin)
ndị na-ebu ụzọ:
Isi: mannitol, microcrystalline cellulose, hydroxypropyl cellulose, ssumumum croscarmellose, magnesium stearate,
Ngwakọta nke akpụkpọ ahụ ihe nkiri: hypromellose 2910, titanium dioxide (E 171), iron oxide yellow (E 172), iron oxide red (E 172), polyethylene glycol 8000, isi awọ ink F1

Nkọwa
Mbadamba ụrọ nke biconvex, nke nwere ihe mkpuchi edo edo, nke akpọrọ “TAK” na “ALG-12.5” n'otu akụkụ nke mbadamba (maka iji dozie 12.5 mg),
Mbadamba ụrọ nke biconvex nke nwere agba gbara agba na-acha uhie uhie nwere mkpụrụ okwu, "TAK" na "ALG-25" n'otu akụkụ nke mbadamba (maka iji ọgwụ were 25 mg).

Ndị na-ere ọgwụ
Pụtara maka ọgwụgwọ maka ọrịa shuga. Ọgwụ shuga dị ala maka nchịkwa ọnụ. Ndị na-egbochi nke dipeptidyl peptidase-4 (DPP-4). Alogliptin

Koodu ATX A10BH04

Ngwongwo ogwu
Mlọ ọgwụ
Achọpụtala ọgwụ ọgwụ nke alogliptin na ọmụmụ metụtara ndị ọrụ afọ ofufo nwere ahụike na ndị ọrịa nwere ụdị shuga 2.N'ime ndị ọrụ afọ ofufo ahụike, mgbe otu onye na-achịkwa ihe ruru 800 mg nke alogliptin, a na-achọpụta nnabata ọgwụ ngwa ngwa site na itinye ọkwa plasma kachasị nke otu elekere abụọ site na oge nchịkwa (nkezi Tmax). Mgbe ị takingụchara ọgwụ ọgwụ kacha akwadoro (25 mg), ọkara ndụ ikpeazụ (T1 / 2) dịkarịa ala awa iri abụọ na abụọ.
Mgbe nchịkwa ugboro ugboro ruo ihe dịka 400 mg maka ụbọchị 14 n'ime ndị ọrịa nwere ọrịa shuga 2, a hụrụ ntakịrị mkpokọta alogliptin na mmụba na mpaghara ahụ n'okpuru usoro ọgwụ pharmacokinetic (AUC) na mkpokọta plasma kachasị (Cmax) site na 34% na 9%, n'otu n'otu. Site na otutu onlogliptin otu na otutu onyoliptin, AUC na Cmax na-abawanye na nha nke mmụba site na 25 mg ruo 400 mg. Ọnụọgụ nke mgbanwe nke AUC nke alogliptin dị n'etiti ndị ọrịa dị obere (17%).
Egwu
Ezigbo bioavailability nke alogliptin bụ ihe dịka 100%. Ebe ọ bụ na mgbe ị na-ewere alogliptin na nri nwere nnukwu abụba, enweghị mmetụta ọ bụla na AUC na Cmax ahụ, enwere ike ị drugụ ọgwụ ahụ n'agbanyeghị nri ahụ.
Nkesa
Mgbe otu nchịkwa introvenous nke alogliptin na onwa nke 12.5 mg na ndị ọrụ afọ ofufo ahụike, olu nkesa n'ime usoro ọnụ bụ 417 L, nke na-egosi na alogliptin na-ekesa nke ọma na anụ ahụ.
Nkwukọrịta na protein protein bụ 20%.
Metabolism
Alogliptin agbasaghị metabolism dị ukwuu, n'ihi nke sitere na 60% ruo 71% nke nchịkwa a na-agbanwe agbanwe na mmamịrị ahụ. Mgbe nchịkwa ọnụ nke 14C nke akara alogliptin, akara metabolites abụọ dị obere: N-demethylated alogliptin M-I (˂1% nke ihe amalite) na N-acetylated alogliptin M-II (˂6% nke ihe amalite). M-I bụ metabolite na-arụsi ọrụ ike ma na-ahọpụta onye na-egbochi DPP-4, nke yiri ya na alogliptin, M-II anaghị egosi ọrụ inhibitory megide DPP-4 ma ọ bụ enzymes DPP ndị ọzọ. Nnyocha ọmụmụ in vitro kpughere na CYP2D6 na CYP3A4 na-atụnye ụtụ metabolism nke alogliptin ụkọ. Alogliptin dịkarịsịrị n'ụdị nke a (R) enantiomer (> 99%) na n'okpuru ọnọdụ vivo na-enweta ntakịrị mgbanwe nke chiral na enantiomer (S). Achọpụtaghị (S) -enantiomer mgbe ị na-alogliptin na usoro ọgwụgwọ (25 mg).
Ojiji
Mgbe nlekọta 14log akara alogliptin akara, 76% nke ngụkọta redioaktivu bụ akụrụ na 13% site na eriri afọ, na-eru 89% nke redio redio na-achịkwa. Mkpochapu nzipu nke alogliptin (9.6 L / h) na-egosi itinye ahihia nzuzo akwara. Nyefee usoro bụ 14.0 l / h.
Pharmacokinetics na otu ọrịa ndị pụrụiche:
Renrụ ọrụ na-arụ ọrụ na ụlọ
AUC nke alogliptin dị na ndị ọrịa nwere ọrụ mgbazinye nsogbu nke nrụgide dị nro (60≤ creatinine nwechapụ (CrCl) A na-ewepụta ozi niile maka ebumnuche gbasara ya, ọ bụghịkwa ihe kpatara onwe-ịkọ ma ọ bụ dochie ọgwụ ahụ.

Ego Vipidia na analogues ya

Ojiji mbadamba ọgwụ Vipidia maka ọrịa shuga na-akacha mma.

Ọ bụrụ na anyị na-ekpebi ọgwụ ahụ site na nyocha ndị mmadụ ji Vipidia hapụ banyere ya, anyị nwere ike ikwubi na ọgwụ bụ ọgwụ dị oke mma nke nwere ike ịchịkwa ogo nke glycemia n'ime ahụ mmadụ na-arịa ụdị ọrịa shuga 2.

O bu ogwu eji eme ihe, nke bu alogliptin rue ta, na mgbakwunye na Vipidia.

Ọgwụ mepụtara, ihe ndị dị ike dị na ya bụ ihe dịịrị ndị otu ahụ.

Ọgwụ ndị a na-ahụkarị bụ analogues nke Vipidia bụ ndị a:

1. Januvia bụ ọgwụ hypoglycemic nke emepụtara na ntọala sitagliptin. Ntọhapụ nke ọgwụ dị n'ụdị mbadamba ụrọ nke nwere 25, 50 na 100 mg nke akụrụngwa na-arụ ọrụ. Ihe ngosi ndi eji eme ya bu ihe ndi Vipidia nwere. Enwere ike iji ọgwụ a nwere monotherapy ma ọ bụ jiri ọgwụgwọ siri ike.
2. Yanumet bu nkwadebe siri ike, nke nwere sitagliptin na metformin dika ihe ndi n’aru. Ọgwụ nke akụkụ mbụ dị n'ọrụ bụ 50 mg, yana metformin n'ụdị ọgwụ ahụ nwere ike ịnwe ọnụọgụ dị iche iche. Ọgwụ dị na ụdị atọ - 50, 850 na 1000 mg.
3. Galvus dị ka akụrụngwa na-arụ ọrụ nwere vildagliptin, nke bụ analogliptin bụ analog. Usoro onodu ogwu eji eme ihe n’ime nkwadebe bu 50 mg. Usoro onodu ogwu nke metformin na mejuputara ogwu ahu bu 500, 850, na 1000 mg.
4. Onglisa na ihe mejuputara ya dika ogige di aru oru nwere saxagliptin. Ngwakọta a metụtara ogige nke na - egbochi ihe enzyme na - eme ka ọ dị mma. Ọgwụ dị na onunu ogwu nke 2.5 na 5 mg.
5. Comboglyz Prolong bụ ngwakọta nke saxagliptin na metformin. Ọgwụ a dị n'ụdị mbadamba. Ntọhapụ nke ihe ndị nọ n'ọrụ na-apụta n'ụdị oge.
6. Trazhenta bụ ọgwụ hypoglycemic mere na ndabere nke linagliptin. Ngwakọta ọgwụ a nwere 5 mg nke ihe mejupụtara ya.

Ọnụ ego ọgwụ na-efu dị na mpaghara a na-ere ọgwụ ahụ na Russia. Ọnụ ego ọgwụ a bụ 843 rubles.

A kọwara ihe ọgwụgwọ ndị ọzọ enwere ike iji gwọọ ọrịa shuga na vidiyo n'isiokwu a.